Viewing Study NCT05617859


Ignite Creation Date: 2025-12-24 @ 2:25 PM
Ignite Modification Date: 2026-03-08 @ 10:37 PM
Study NCT ID: NCT05617859
Status: RECRUITING
Last Update Posted: 2023-08-21
First Post: 2022-10-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenvatinib for Advanced Bone and Soft Tissue Sarcoma
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module